Rigel Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Sublease Agreement (Tables)

9 Months Ended

Sep. 30, 2015

The changes in the liability related to the sublease agreement for the nine months ended September 30, 2015 were as follows (in thousands):


Balance at January 1, 2015	$	9,269
Accretion of deferred liability		437
Amortization of deferred liability		(2,522)
Balance at September 30, 2015	$	7,184